Exalenz Bioscience's Other Investors

Exalenz Bioscience raised a round of funding on , . Investors include Accelmed.

Exalenz Bioscience Ltd. (TASE:EXEN) develops and commercializes advanced systems for diagnosing and managing a broad range of GI and liver conditions. The company's flagship product, BreathID Hp, is a…

Articles about Exalenz Bioscience's Other Investors: